CAM
Close Asset Management Portfolio holdings
AUM
$3.42B
This Quarter Return
+9.65%
1 Year Return
+20.4%
3 Year Return
+78.01%
5 Year Return
+124.39%
10 Year Return
–
AUM
$2.39B
AUM Growth
+$2.39B
(+23%)
Cap. Flow
+$300M
Cap. Flow
% of AUM
12.57%
Top 10 Holdings %
Top 10 Hldgs %
53.09%
Holding
254
New
15
Increased
76
Reduced
51
Closed
8
Top Buys
| 1 |
Amazon
AMZN
|
$129M |
| 2 |
Abbott
ABT
|
$81.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$24.2M |
| 4 |
Cooper Companies
COO
|
$23.9M |
| 5 |
Dover
DOV
|
$11.6M |
Top Sells
| 1 |
Casey's General Stores
CASY
|
$41.5M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$11.4M |
| 3 |
Cenovus Energy
CVE
|
$9.13M |
| 4 |
Bristol-Myers Squibb
BMY
|
$2.59M |
| 5 |
KKR & Co
KKR
|
$2.41M |
Sector Composition
| 1 | Financials | 21.78% |
| 2 | Technology | 19.16% |
| 3 | Healthcare | 18.73% |
| 4 | Communication Services | 10.19% |
| 5 | Consumer Discretionary | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
DNOW Inc
DNOW
$1.68B
| $47K | ﹤0.01% |
4,159
| – | – |
|
152
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$325M
| $46K | ﹤0.01% |
+3,034
| New | +$46K |
|
|
B
153
Barrick Mining Corporation
B
$45.4B
| $44K | ﹤0.01% |
2,424
| – | – |
|
154
HubSpot
HUBS
$25.5B
| $42K | ﹤0.01% |
73
+30
| +70% | +$17.3K |
|
155
Illumina
ILMN
$15.8B
| $42K | ﹤0.01% |
300
-1,507
| -83% | -$211K |
|
156
Keurig Dr Pepper
KDP
$39.5B
| $42K | ﹤0.01% |
1,273
-1,018
| -44% | -$33.6K |
|
157
Hershey
HSY
$37.3B
| $40K | ﹤0.01% |
214
+56
| +35% | +$10.5K |
|
158
Fortuna Silver Mines
FSM
$2.36B
| $39K | ﹤0.01% |
10,000
| – | – |
|
159
Embecta
EMBC
$847M
| $38K | ﹤0.01% |
2,013
-53
| -3% | -$1K |
|
160
FMC
FMC
$4.88B
| $37K | ﹤0.01% |
590
-91
| -13% | -$5.71K |
|
161
Ameriprise Financial
AMP
$48.5B
| $36K | ﹤0.01% |
95
| – | – |
|
162
Moderna
MRNA
$9.37B
| $35K | ﹤0.01% |
350
| – | – |
|
163
Neurocrine Biosciences
NBIX
$13.8B
| $35K | ﹤0.01% |
268
| – | – |
|
164
Albemarle
ALB
$9.99B
| $33K | ﹤0.01% |
230
-115
| -33% | -$16.5K |
|
165
DexCom
DXCM
$29.5B
| $33K | ﹤0.01% |
264
| – | – |
|
166
L3Harris
LHX
$51.9B
| $32K | ﹤0.01% |
150
| – | – |
|
167
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.23B
| $32K | ﹤0.01% |
1,170
| – | – |
|
168
iShares Biotechnology ETF
IBB
$5.6B
| $31K | ﹤0.01% |
230
-78
| -25% | -$10.5K |
|
169
HP
HPQ
$26.7B
| $30K | ﹤0.01% |
1,000
| – | – |
|
170
Gold Fields
GFI
$30B
| $27K | ﹤0.01% |
1,900
-2,450
| -56% | -$34.8K |
|
171
HCA Healthcare
HCA
$94.5B
| $27K | ﹤0.01% |
100
| – | – |
|
172
Oramed Pharmaceuticals
ORMP
$90.2M
| $26K | ﹤0.01% |
11,400
| – | – |
|
173
Ashland
ASH
$2.57B
| $23K | ﹤0.01% |
275
| – | – |
|
174
NetEase
NTES
$86.2B
| $23K | ﹤0.01% |
250
| – | – |
|
175
Interactive Strength
TRNR
$6.64M
| $22K | ﹤0.01% |
24,612
| – | – |
|